Skip to content
TrialScanner

NCT00759135

Phase 2 Study of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) (Enlarged Prostate)

Phase 2CompletedNYMXFLead

Registry record

Lead sponsor
Nymox Corporation
Conditions
Benign Prostatic Hyperplasia (BPH); Enlarged Prostate
Primary completion
Jan 2008Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00759135 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00759135: Phase 2 Study of NX-1207 for... | TrialScanner